View Older Stories View More Recent Stories

Feb 18, 2021 01:32PM Pfizer (PFE), BioNTech (BNTX) Starts Trial to Evaluate COVID-19 Vaccine in Pregnant Women
Feb 18, 2021 01:30PM Pfizer and BioNTech Commence Global Clinical Trial to Evaluate COVID-19 Vaccine in Pregnant Women
Feb 17, 2021 05:15PM In Vitro Study Published in NEJM Demonstrates Sera from Individuals Immunized with the Pfizer (PFE) -BioNTech (BNTX) COVID-19 Vaccine Neutralize SARS-CoV-2 with South African Variant Spike Mutations
Feb 17, 2021 05:13PM In Vitro Study Published in The New England Journal of Medicine Demonstrates Sera from Individuals Immunized with the Pfizer-BioNTech COVID-19 Vaccine Neutralize SARS-CoV-2 with South African Variant
Feb 17, 2021 05:04PM Myovant Sciences (MYOV), Pfizer (PFE) Announce Publication in NEJM of Phase 3 LIBERTY Studies of Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids
Feb 17, 2021 05:02PM Myovant Sciences and Pfizer Announce Publication in the New England Journal of Medicine of Phase 3 LIBERTY Studies of Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids
Feb 17, 2021 05:02PM Myovant Sciences and Pfizer Announce Publication in the New England Journal of Medicine of Phase 3 LIBERTY Studies of Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids
Feb 17, 2021 06:48AM Pfizer (PFE) Initiates Pivotal Phase 2 MagnetisMM-3 Trial of BCMA-CD3 Bispecific Antibody Elranatamab (PF-06863135) in Multiple Myeloma
Feb 17, 2021 06:45AM Pfizer Initiates Pivotal Phase 2 MagnetisMM-3 Trial of BCMA-CD3 Bispecific Antibody Elranatamab (PF-06863135) in Multiple Myeloma
Feb 17, 2021 06:20AM Pfizer (PFE) and BioNTech (BNTX) to Supply European Union with 200 Million Additional Doses of COVID-19 Vaccine
Feb 17, 2021 04:00AM Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®
Feb 17, 2021 04:00AM Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®
Feb 12, 2021 05:10PM U.S. FDA Approves PANZYGA® for the Treatment of Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Feb 12, 2021 08:30AM Pfizer (PFE), BioNTech (BNTX) to Supply the United States with 100 Million Additional Doses of COVID-19 Vaccine
Feb 12, 2021 08:30AM Pfizer and BioNTech to Supply the United States with 100 Million Additional Doses of COVID-19 Vaccine
Feb 9, 2021 07:30AM Nextech AR’s Virtual Event Platform Selected by Canadian Surgery Forum for Its 2021 Virtual Trade Show
Feb 5, 2021 06:47AM Pfizer (PFE) Confirms U.S. Patent Term Extension for IBRANCE (palbociclib) Until March 2027
Feb 5, 2021 06:45AM Pfizer Confirms U.S. Patent Term Extension for IBRANCE® (palbociclib) Until March 2027
Feb 1, 2021 08:35AM Pfizer (PFE) and BioNTech (BNTX) Publish Preclinical Data from Investigational COVID-19 Vaccine Program in Nature
Feb 1, 2021 08:32AM Pfizer and BioNTech Publish Preclinical Data from Investigational COVID-19 Vaccine Program in Nature
Jan 27, 2021 06:46AM Pfizer (PFE) Shares Co-Primary Endpoint Results from Post-Marketing Required Safety Study of XELJANZ in Subjects with RA
Jan 27, 2021 06:45AM Pfizer Shares Co-Primary Endpoint Results from Post-Marketing Required Safety Study of XELJANZ® (tofacitinib) in Subjects with Rheumatoid Arthritis (RA)
Jan 26, 2021 06:58AM Myovant Sciences (MYOV) , Pfizer (PFE) Announce Positive One-Year Data from Phase 3 SPIRIT Extension Study of Once-Daily Relugolix Combination Therapy in Women with Endometriosis
Jan 26, 2021 06:55AM Myovant Sciences and Pfizer Announce Positive One-Year Data from Phase 3 SPIRIT Extension Study of Once-Daily Relugolix Combination Therapy in Women with Endometriosis
Jan 26, 2021 06:55AM Myovant Sciences and Pfizer Announce Positive One-Year Data from Phase 3 SPIRIT Extension Study of Once-Daily Relugolix Combination Therapy in Women with Endometriosis
Jan 25, 2021 06:00AM Pfizer (PFE) and EMD Serono Report European Commission Approves BAVENCIO (avelumab) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Jan 25, 2021 02:00AM European Commission Approves BAVENCIO® (avelumab) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Jan 22, 2021 12:01PM Pfizer (PFE), BioNTech (BNTX) Reach Agreement with COVAX for Advance Purchase of Vaccine to Help Combat COVID-19
Jan 22, 2021 12:00PM Pfizer and BioNTech Reach Agreement with COVAX for Advance Purchase of Vaccine to Help Combat COVID-19
Jan 20, 2021 07:50AM Pfizer (PFE), BioNTech (BNTX) Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture
Jan 20, 2021 07:50AM Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture
Jan 14, 2021 04:32PM Pfizer (PFE) Announces XALKORI Approved by FDA for ALK-positive Anaplastic Large Cell Lymphoma in Children and Young Adults
Jan 14, 2021 04:30PM Pfizer’s XALKORI® (crizotinib) Approved by FDA for ALK-positive Anaplastic Large Cell Lymphoma in Children and Young Adults
Jan 12, 2021 06:52AM PureTech (PRTC) Founded Entity Vedanta Biosciences Announces $25 Million Investment from Pfizer Inc.
Jan 12, 2021 06:50AM PureTech Founded Entity Vedanta Biosciences Announces $25 Million Investment from Pfizer Inc.
Jan 12, 2021 06:45AM Pfizer Invests $120 Million in Biotechnology Innovation Through the Pfizer Breakthrough Growth Initiative
Jan 8, 2021 06:18AM Pfizer (PFE), BioNTech SE (BNTX) Study Shows its COVID-19 Vaccine Works on More Contagious U.K. Strain
Jan 8, 2021 05:45AM An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission
Jan 7, 2021 06:56AM Pfizer (PFE) Doses First Participant in Phase 3 Study for Duchenne Muscular Dystrophy Investigational Gene Therapy
Jan 7, 2021 06:45AM Pfizer Doses First Participant in Phase 3 Study for Duchenne Muscular Dystrophy Investigational Gene Therapy
Jan 6, 2021 07:00AM Dewpoint Announces Collaboration with Pfizer to Develop Potential Therapies for a Rare Form of Muscular Dystrophy
Jan 5, 2021 10:00AM Pfizer Invites Public to Listen to Two Webcasts of Pfizer Discussions at Healthcare Conference
Jan 4, 2021 06:46AM Pfizer (PFE), OPKO Health (OPK) Announce FDA Accepts Regulatory Submission for Review of Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency
Jan 4, 2021 06:45AM US FDA Accepts Regulatory Submission from Pfizer and OPKO for Review of Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency
Dec 29, 2020 01:13PM Pfizer (PFE), BioNTech (BNTX) to Supply the European Union with 100 Million Additional COVID-19 Vaccine Doses
Dec 29, 2020 01:11PM Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®
Dec 29, 2020 01:10PM Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®
Dec 28, 2020 04:30PM LORBRENA® (lorlatinib) sNDA in Previously Untreated ALK-Positive Lung Cancer Accepted for Priority Review by U.S. FDA
Dec 28, 2020 09:37AM UPDATE - Sumitovant Biopharma Announces Myovant Sciences and Pfizer Enter Collaboration to Develop and Commercialize Relugolix in Oncology and Women’s Health
Dec 28, 2020 06:55AM Sumitovant Biopharma Announces Myovant Sciences and Pfizer Enter Collaboration to Develop and Commercialize Relugolix in Oncology and Women’s Health
View More Recent Stories View Older Stories